搜尋
NovaBay Pharmaceuticals Inc
NBY添加自選
1.950USD
0.0000.00%
收盤 07/02, 13:00（美東）報價延遲15分鐘
68.61M總市值
虧損本益比TTM
關於 NovaBay Pharmaceuticals Inc 公司
NovaBay Pharmaceuticals, Inc. is engaged in wound care products. The Company manufactures and sells its proprietary form of hypochlorous acid for the wound care market through its NeutroPhase and PhaseOne branded products. NeutroPhase and PhaseOne are used for cleansing and irrigation as part of surgical procedures, as well as treating wounds, burns, ulcers and other injuries.
NovaBay Pharmaceuticals Inc簡介
公司代碼NBY
公司名稱NovaBay Pharmaceuticals Inc
上市日期Oct 26, 2007
CEOKazley (Michael John)
員工數量14
證券類型Ordinary Share
年結日Oct 26
公司地址2000 Powell St Ste 1150
城市EMERYVILLE
上市交易所NASDAQ OMX – NASDAQ Basic Amex
國家United States of America
郵編94608-1804
電話15108998800
網址https://novabay.com/
公司代碼NBY
上市日期Oct 26, 2007
CEOKazley (Michael John)
NovaBay Pharmaceuticals Inc公司高管
名稱
名稱/職務
職務
持股
持股變動
Ms. Swan Sit
Ms. Swan Sit
Independent Director
Independent Director
172.00
-10.47%
Mr. Tommy Law
Mr. Tommy Law
Chief Financial Officer, Treasurer
Chief Financial Officer, Treasurer
6.00
+16.67%
Mr. Paul E. Freiman, Ph.D.
Mr. Paul E. Freiman, Ph.D.
Director
Director
--
--
Mr. Justin M. Hall, Esq.
Mr. Justin M. Hall, Esq.
Vice President - Business Development, General Counsel, Corporate Secretary
Vice President - Business Development, General Counsel, Corporate Secretary
--
--
Dr. Yenyou (Jeff) Zheng, Ph.D.
Dr. Yenyou (Jeff) Zheng, Ph.D.
Independent Director
Independent Director
--
--
Capt. Jody Cain
Capt. Jody Cain
IR Contact Officer
IR Contact Officer
--
--
Mr. Michael Kazley
Mr. Michael Kazley
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
--
--
名稱
名稱/職務
職務
持股
持股變動
Ms. Swan Sit
Ms. Swan Sit
Independent Director
Independent Director
172.00
-10.47%
Mr. Tommy Law
Mr. Tommy Law
Chief Financial Officer, Treasurer
Chief Financial Officer, Treasurer
6.00
+16.67%
Mr. Paul E. Freiman, Ph.D.
Mr. Paul E. Freiman, Ph.D.
Director
Director
--
--
Mr. Justin M. Hall, Esq.
Mr. Justin M. Hall, Esq.
Vice President - Business Development, General Counsel, Corporate Secretary
Vice President - Business Development, General Counsel, Corporate Secretary
--
--
Dr. Yenyou (Jeff) Zheng, Ph.D.
Dr. Yenyou (Jeff) Zheng, Ph.D.
Independent Director
Independent Director
--
--
Capt. Jody Cain
Capt. Jody Cain
IR Contact Officer
IR Contact Officer
--
--
常見問題
NovaBay Pharmaceuticals Inc的前五大股東是誰？
NovaBay Pharmaceuticals Inc的前五大股東如下：Ms. Swan Sit
有多少機構持有NovaBay Pharmaceuticals Inc(NBY)的股份？
截至2026Q1，共有47家機構持有NovaBay Pharmaceuticals Inc的股份，合計持有的股份價值約為1.80M，占公司總股份的6.77% 。與2025Q4相比，機構持股有所增加，增幅為1464094.00。